Grey matter ageing-related tau astrogliopathy: associations with brain pathologies and cognitive decline.

IF 10.6 1区 医学 Q1 CLINICAL NEUROLOGY
Brain Pub Date : 2024-10-03 DOI:10.1093/brain/awae250
Sonal Agrawal, Lei Yu, Sue E Leurgans, Alifiya Kapasi, Lisa L Barnes, David A Bennett, Patricia A Boyle, Julie A Schneider
{"title":"Grey matter ageing-related tau astrogliopathy: associations with brain pathologies and cognitive decline.","authors":"Sonal Agrawal, Lei Yu, Sue E Leurgans, Alifiya Kapasi, Lisa L Barnes, David A Bennett, Patricia A Boyle, Julie A Schneider","doi":"10.1093/brain/awae250","DOIUrl":null,"url":null,"abstract":"<p><p>Grey matter ageing-related tau astrogliopathy (ARTAG) pathology is common in aged brains and detected in multiple brain regions. However, the associations of grey matter ARTAG with Alzheimer's disease and other common age-related proteinopathies, in addition to clinical phenotypes, including Alzheimer's dementia and cognitive decline, remain unclear. We examined 442 decedents (mean age at death = 90 years, males = 32%) from three longitudinal community-based clinical-pathological studies. Using AT8 immunohistochemistry, grey matter ARTAG pathology was counted in the superior frontal region, anterior temporal tip and amygdala and summarized as a severity score ranging from zero (none) to six (severe). Alzheimer's disease and other common age-related neuropathologies were also evaluated. The diagnosis of Alzheimer's dementia was based on clinical evaluations; annual tests of cognitive performance were summarized as global cognition and five cognitive domains. Multivariable logistic regression tested the associations of grey matter ARTAG pathology with an array of age-related neuropathologies. To evaluate associations of grey matter ARTAG pathology with Alzheimer's dementia and cognitive decline, we used logistic regression and linear mixed-effect models. Grey matter ARTAG pathology was seen in 324 (73%) participants, of which 303 (68%) participants had ARTAG in the amygdala, 246 (56%) in the anterior temporal tip and 137 (31%) in the superior frontal region. Grey matter ARTAG pathology from each of the three regions was associated with a pathological diagnosis of Alzheimer's disease and limbic-predominant age-related TAR DNA-binding protein 43 encephalopathy-neuropathological change but not with vascular pathology. In fully adjusted models that controlled for demographics, Alzheimer's disease and common age-related pathologies, an increase in severity of grey matter ARTAG pathology in the superior frontal cortex, but not in the amygdala or the anterior temporal tip, was associated with higher odds of Alzheimer's dementia and faster decline in global cognition, episodic memory and semantic memory. These results provide compelling evidence that grey matter ARTAG, specifically in the superior frontal cortex, contributes to Alzheimer's dementia and cognitive decline in old age.</p>","PeriodicalId":9063,"journal":{"name":"Brain","volume":null,"pages":null},"PeriodicalIF":10.6000,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11449137/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/brain/awae250","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Grey matter ageing-related tau astrogliopathy (ARTAG) pathology is common in aged brains and detected in multiple brain regions. However, the associations of grey matter ARTAG with Alzheimer's disease and other common age-related proteinopathies, in addition to clinical phenotypes, including Alzheimer's dementia and cognitive decline, remain unclear. We examined 442 decedents (mean age at death = 90 years, males = 32%) from three longitudinal community-based clinical-pathological studies. Using AT8 immunohistochemistry, grey matter ARTAG pathology was counted in the superior frontal region, anterior temporal tip and amygdala and summarized as a severity score ranging from zero (none) to six (severe). Alzheimer's disease and other common age-related neuropathologies were also evaluated. The diagnosis of Alzheimer's dementia was based on clinical evaluations; annual tests of cognitive performance were summarized as global cognition and five cognitive domains. Multivariable logistic regression tested the associations of grey matter ARTAG pathology with an array of age-related neuropathologies. To evaluate associations of grey matter ARTAG pathology with Alzheimer's dementia and cognitive decline, we used logistic regression and linear mixed-effect models. Grey matter ARTAG pathology was seen in 324 (73%) participants, of which 303 (68%) participants had ARTAG in the amygdala, 246 (56%) in the anterior temporal tip and 137 (31%) in the superior frontal region. Grey matter ARTAG pathology from each of the three regions was associated with a pathological diagnosis of Alzheimer's disease and limbic-predominant age-related TAR DNA-binding protein 43 encephalopathy-neuropathological change but not with vascular pathology. In fully adjusted models that controlled for demographics, Alzheimer's disease and common age-related pathologies, an increase in severity of grey matter ARTAG pathology in the superior frontal cortex, but not in the amygdala or the anterior temporal tip, was associated with higher odds of Alzheimer's dementia and faster decline in global cognition, episodic memory and semantic memory. These results provide compelling evidence that grey matter ARTAG, specifically in the superior frontal cortex, contributes to Alzheimer's dementia and cognitive decline in old age.

与灰质老化相关的 tau 星形胶质细胞病变:与大脑病变和认知能力下降的关联。
灰质 ARTAG 病理学在老年大脑中很常见,可在多个脑区检测到。然而,灰质 ARTAG 与阿尔茨海默病(AD)和其他常见老年相关蛋白病以及包括阿尔茨海默氏症痴呆和认知能力下降在内的临床表型之间的关系仍不清楚。我们研究了三项基于社区的纵向临床病理学研究中的 442 位死者(平均死亡年龄=90 岁,男性=32%)。我们使用 AT8 免疫组化技术对额叶上部、颞叶前端和杏仁核的灰质 ARTAG 病变进行了计数,并将其总结为从 0(无)到 6(严重)的严重程度评分。此外,还评估了老年痴呆症和其他常见的与年龄有关的神经病理学。阿尔茨海默氏症痴呆的诊断基于临床评估;认知能力的年度测试总结为总体认知能力和五个认知领域。多变量逻辑回归测试了灰质 ARTAG 病理学与一系列年龄相关神经病理学的关联。为了评估灰质 ARTAG 病变与阿尔茨海默氏症痴呆和认知能力下降之间的关联,我们采用了逻辑回归和线性混合效应模型。324名参与者(73%)出现了灰质ARTAG病变,其中303名参与者(68%)的杏仁核出现了ARTAG,246名参与者(56%)的颞叶前端出现了ARTAG,137名参与者(31%)的额叶上部出现了ARTAG。这三个区域的灰质 ARTAG 病变均与 AD 和 LATE-NC 的病理诊断有关,但与血管病变无关。在控制了人口统计学、注意力缺失症和常见年龄相关病症的完全调整模型中,额叶上皮层灰质 ARTAG 病变严重程度的增加与阿尔茨海默氏症痴呆症几率的升高有关,而与杏仁核或颞叶前端的病变严重程度无关,并且与整体认知、情节记忆和语义记忆的快速衰退有关。这些结果提供了令人信服的证据,证明灰质ARTAG,特别是额叶上皮层的灰质ARTAG是阿尔茨海默氏症痴呆症和老年认知能力下降的原因。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Brain
Brain 医学-临床神经学
CiteScore
20.30
自引率
4.10%
发文量
458
审稿时长
3-6 weeks
期刊介绍: Brain, a journal focused on clinical neurology and translational neuroscience, has been publishing landmark papers since 1878. The journal aims to expand its scope by including studies that shed light on disease mechanisms and conducting innovative clinical trials for brain disorders. With a wide range of topics covered, the Editorial Board represents the international readership and diverse coverage of the journal. Accepted articles are promptly posted online, typically within a few weeks of acceptance. As of 2022, Brain holds an impressive impact factor of 14.5, according to the Journal Citation Reports.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信